CID 719793

N-[2-(1h-benzimidazol-2-yl)ethyl]-3-bromobenzamide

Structural Information

Molecular Formula
C16H14BrN3O
SMILES
C1=CC=C2C(=C1)NC(=N2)CCNC(=O)C3=CC(=CC=C3)Br
InChI
InChI=1S/C16H14BrN3O/c17-12-5-3-4-11(10-12)16(21)18-9-8-15-19-13-6-1-2-7-14(13)20-15/h1-7,10H,8-9H2,(H,18,21)(H,19,20)
InChIKey
HKYPRNSPCNMSQK-UHFFFAOYSA-N
Compound name
N-[2-(1H-benzimidazol-2-yl)ethyl]-3-bromobenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

7
References

4
Patents

343.032 Da
Monoisotopic Mass

3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 344.039276 170.8
[M+Na]+ 366.021218 181.8
[M-H]- 342.024724 177.4
[M+NH4]+ 361.065823 187.1
[M+K]+ 381.995158 168.3
[M+H-H2O]+ 326.029260 168.6
[M+HCOO]- 388.030201 190.4
[M+CH3COO]- 402.045851 183.4
[M+Na-2H]- 364.006666 177.4
[M]+ 343.03145142 189.5
[M]- 343.03254858 189.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe